UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2026 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...
2026 Q3 Form 10-Q
Filed with ASX · · 46 pages · English
Summary by 6ix AI
The report includes condensed consolidated financial statements, management's discussion, and analysis of financial condition and results of operations. It highlights significant figures such as total assets, liabilities, and stockholders' equity, along with revenues and net loss for the quarter. The document is prepared in accordance with U.S. GAAP and includes unaudited financial information.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/2026-q3-form-10-q-1
Release
Imricor Medical Systems, Inc. on 6ix
Earlier from Imricor Medical Systems
- Q3 CY2026 Quarterly Activities Report & Form 10-Q Submission
- Q3 FY26 Results Webinar Notification
- Notification of cessation of securities - IMR
- Notification regarding unquoted securities - IMR
- FDA Completes Review of Third PMA Module
